Evidence map›Paper›PMID 35419640›Full record

ReviewBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2022

[Frequently asked questions (FAQ) in risk communication about COVID-19: creation and significance as an inter-institutional rapid reaction tool].

Linda Seefeld, Florentine Frentz, Nina Horstkötter, Christoph Peter, Martin Dietrich

Abstract readReview
In one paragraph

Review in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Linda SeefeldReferat "Infektionsschutz, Risiko- und Krisenmanagement", Bundeszentrale für gesundheitliche Aufklärung, Köln, Deutschland. Linda.Seefeld@bzga.de.
Florentine FrentzReferat "Infektionsschutz, Risiko- und Krisenmanagement", Bundeszentrale für gesundheitliche Aufklärung, Köln, Deutschland.
Nina HorstkötterReferat "Infektionsschutz, Risiko- und Krisenmanagement", Bundeszentrale für gesundheitliche Aufklärung, Köln, Deutschland.
Christoph PeterReferat "Infektionsschutz, Risiko- und Krisenmanagement", Bundeszentrale für gesundheitliche Aufklärung, Köln, Deutschland.
Martin DietrichReferat "Infektionsschutz, Risiko- und Krisenmanagement", Bundeszentrale für gesundheitliche Aufklärung, Köln, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In addition to the national pandemic plan to cope with the COVID-19 pandemic, it is stipulated that the Federal Centre for Health Education (BZgA) provides information on coronavirus SARS-CoV‑2 for the general population via a subpage of www.infektionsschutz.de . In particular, the informational material should contain answers to frequently asked questions (FAQ) as well as behavioural recommendations for prevention.This article describes how information content is created ad hoc in the form of FAQ and why these FAQ are significant for crisis communication. The evolution of the FAQ from a simple information instrument to an inter-institutional rapid reaction tool in the context of risk communication on COVID-19 becomes clear. Close cooperation between the authorities is required to ensure that information is provided in a congruent and up-to-date manner. The work and coordination processes as well as various update procedures are presented. Theoretical implications for crisis communication and crisis management can be derived from the work processes described and assessed.These processes can be taken up by other institutions as examples of good practice and, if necessary, further developed and/or transferred to other contexts.

Indexed as

COVID-19CommunicationGermanyHumansPandemicsSARS-CoV-2CoronavirusCrisis managementFederal CenterHealth educationPandemicRisk communicationSARS-CoV‑2

Identifiers

PMID35419640
PMCPMC9007052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.